Univadis - a service form MSD

A trusted medical reference

Create an account Log in

app catalog Search

Log in

Close

My Account

Loading...

Medical News Medical Quiz eLearning Conference Reports Delete Oncology Radiology Collection Delete PubMed Delete Image & Media Library Delete Link Library Delete MSD Manual Delete Patient Resource Centre Install new apps

See all my apps Hide my apps

Install new apps Manage my apps

Rearrange your apps by dragging them or delete them with the cross.

Save Cancel

Welcome. Please log in or create an account.

Log in

Remember me (Uncheck if on a shared computer)

Forgot your Password ?

Please review the fields marked in red and resubmit the form

Create an account

Register to access independent medical news and resources from Univadis^®

Latest updates

Medical News

The European Commission has launched the 2019 REGIOSTARS Awards this week.

European Commission to reward projects that help modernise health services

Univadis Medical News
22 February 2019

The European Commission has launched the 2019 REGIOSTARS Awards this week.

New data suggest more than half of health spending in low- and middle-income countries is devoted to primary health care.

Global health spending on the rise - WHO report

Univadis Medical News
22 February 2019

New data suggest more than half of health spending in low- and middle-income countries is devoted to primary health care.

Updated ESMO guideline on the treatment of hepatocellular cancer now includes lenvatinib and cabozantinib.

Hepatocellular cancer: ESMO updates treatment guidance

Univadis Medical News
22 February 2019

Updated ESMO guideline on the treatment of hepatocellular cancer now includes lenvatinib and cabozantinib.

More Medical News >

Conference Reports

ASCO-GU 2019—Adjuvant chemotherapy + postop radiotherapy improves DFS, OS in locally advanced urothelial carcinoma

Univadis
19 February 2019

Post-hoc analysis of phase 3 trial results.

ASCO-GU 2019—Avelumab+axitinib bests sunitinib in previously untreated clear-cell aRCC

Univadis
19 February 2019

Results from the ongoing JAVELIN Renal 101 phase 3 trial.

ASCO-GU 2019—Darolutamide improves MFS in castration-resistant prostate cancer

Univadis
19 February 2019

Darolutamide may offer an alternative to apalutamide and enzalutamide.

More Conference Reports >

Featured Channels

application icon

Oncology Oncology essentials all in one place

application icon

Zika All you need to know about Zika virus

Keep up with oncology literature in minutes, every day

Get your daily dose of the latest evidence published in your cancer area of practice
Get my daily Newsletter

Univadis^®

Univadis^®, provided by MSD, brings you unbiased, relevant medical news as well as helpful resources for your daily practice at no cost.

Our Partners

Univadis^® brings together premium content publishers that deliver comprehensive and up-to-date medical information.

Contact Us

E-mail Us

Complete contact form >

MSD does not endorse and is not responsible for the accuracy of the content, or for practices or standards of non-MSD sources. Please read our Terms of Use for more information

Privacy Policy | Transparency Policy

Copyright © 2019 Aptus Health International, Inc. All rights reserved.